OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metformin Ameliorates Chronic Colitis-Related Intestinal Fibrosis via Inhibiting TGF-β1/Smad3 Signaling
Ying Wang, Zhi Wang, Huiping Yang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11

Showing 11 citing articles:

The role of Nrf2 in the pathogenesis and treatment of ulcerative colitis
Shuai Peng, Lei Shen, Xiaoyun Yu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 33

Triggerable Prodrug Nanocoating Enables On-Demand Activation of Microbial and Small-Molecular Therapeutics for Combination Treatment
Xiao Kuang, Ying Liu, Huilong Luo, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 49, pp. 26932-26946
Closed Access | Times Cited: 24

A Narrative Review of Cytokine Networks: Pathophysiological and Therapeutic Implications for Inflammatory Bowel Disease Pathogenesis
Marek Vébr, Renata Pomahačová, Josef Sýkora, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3229-3229
Open Access | Times Cited: 23

Ternary inulin hydrogel with long-term intestinal retention for simultaneously reversing IBD and its fibrotic complication
Xiangjing Cao, Tao Shi, Weitao Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9

Mechanism of Action and Therapeutic Implications of Nrf2/HO-1 in Inflammatory Bowel Disease
Lingling Yuan, Yingyi Wang, Na Li, et al.
Antioxidants (2024) Vol. 13, Iss. 8, pp. 1012-1012
Open Access | Times Cited: 6

Use of glucagon‐like peptide‐1 receptor agonists for type 2 diabetes mellitus and outcomes of inflammatory bowel disease
Aakash Desai, Jessica C. Petrov, Jana G. Hashash, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 5, pp. 620-632
Closed Access | Times Cited: 5

AMPK activation alleviated dextran sulfate sodium‐induced colitis by inhibiting ferroptosis
Shaopeng Sun, Bin Lü, Heng Li, et al.
Journal of Digestive Diseases (2023) Vol. 24, Iss. 3, pp. 213-223
Closed Access | Times Cited: 10

Intestinal Stromal Cells in the Turmoil of Inflammation and Defective Connective Tissue Remodeling in Inflammatory Bowel Disease
Ioannis Drygiannakis, George Kolios, Eirini Filidou, et al.
Inflammatory Bowel Diseases (2024) Vol. 30, Iss. 9, pp. 1604-1618
Closed Access | Times Cited: 2

Metformin relieves bone cancer pain by reducing TGFβRI-TRPV1 signaling in rats
Fang Zhou, He-Ya Qian, Ke Wang, et al.
Heliyon (2024) Vol. 10, Iss. 15, pp. e34991-e34991
Open Access | Times Cited: 1

Combinatorial intervention with dental pulp stem cells and sulfasalazine in a rat model of ulcerative colitis
Riham M. Aly, Rehab S. Abohashem, Hanaa H. Ahmed, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 6, pp. 3863-3879
Open Access

Inflammatory Bowel Diseases in Spain: A View from the Present to the Future
Raquel Francés, Yuanji Fu, Christophe Desterke, et al.
J — Multidisciplinary Scientific Journal (2024) Vol. 7, Iss. 4, pp. 489-501
Open Access

Page 1

Scroll to top